Briefing.com is the leading Internet provider of live market analysis for U.S. Stock, U.S. Bond, and world FX market participants.
Read more In play articles
Market Report -- In Play (CBM)
February 14, 2013 9:31 AM ET
Cambrex and Dow Chemical (DOW) collaborate to manufacture drug-solubility solution Co and The Dow Chemical Company (DOW) have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility Enhancement. This is the final step in building on the solubilization partnership that Dow and Bend Research announced in October 2012 and it will help Dow to commercially supply solubility enabling excipients.
RELATED VIDEOS
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
YOUR RECENT NEWS SEARCHES
STOCKS MENTIONED IN THIS ARTICLE
- Cambrex Corp (CBM)
MOST REPORTED
Stocks
| JPMorgan Chase & Co (JPM) | 62 Stories... |
| Apple Inc (AAPL) | 51 Stories... |
| Yahoo! Inc (YHOO) | 36 Stories... |
| Home Depot Inc (HD) | 34 Stories... |
| Google Inc (GOOG) | 26 Stories... |
RECENT QUOTES
WATCHLIST
Sponsored by: